Table of Content


"1    INTRODUCTION    41
1.1    OBJECTIVES OF THE STUDY    41
1.2    MARKET DEFINITION    42
1.2.1    INCLUSIONS & EXCLUSIONS    42
1.3    MARKET SCOPE    43
1.3.1    MARKETS COVERED    43
FIGURE 1    WESTERN BLOTTING MARKET SEGMENTATION    43
1.3.2    YEARS CONSIDERED FOR THE STUDY    43
1.4    CURRENCY    44
1.5    LIMITATIONS    44
1.6    STAKEHOLDERS    44
1.7    SUMMARY OF CHANGES    45
2    RESEARCH METHODOLOGY    46
2.1    RESEARCH DATA    46
FIGURE 2    RESEARCH DESIGN    46
2.1.1    SECONDARY DATA    46
2.1.2    PRIMARY DATA    47
FIGURE 3    PRIMARY SOURCES    48
FIGURE 4    WESTERN BLOTTING MARKET: BREAKDOWN OF PRIMARIES    48
2.1.2.1    Key industry insights    49
2.2    MARKET SIZE ESTIMATION    50
FIGURE 5    MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS, 2020    50
FIGURE 6    MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP (SUPPLY SIDE) – COLLECTIVE REVENUE OF ALL WESTERN BLOTTING PRODUCTS    50
FIGURE 7    WESTERN BLOTTING MARKET: CAGR PROJECTIONS, 2021–2026    52
FIGURE 8    WESTERN BLOTTING MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS OPPORTUNITIES, AND CHALLENGES    52
2.3    MARKET BREAKDOWN AND DATA TRIANGULATION    54
FIGURE 9    DATA TRIANGULATION METHODOLOGY    54
2.4    RESEARCH LIMITATIONS    55
2.5    GROWTH RATE ASSUMPTIONS    55
2.6    RISK ANALYSIS    56
3    EXECUTIVE SUMMARY    57
FIGURE 10    WESTERN BLOTTING MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)    57
FIGURE 11    WESTERN BLOTTING MARKET, BY APPLICATION,
2021 VS. 2026 (USD MILLION)    58
FIGURE 12    WESTERN BLOTTING MARKET SHARE, BY END USER, 2020    58
FIGURE 13    GEOGRAPHICAL SNAPSHOT OF THE WESTERN BLOTTING MARKET    59
4    PREMIUM INSIGHTS    60
4.1    WESTERN BLOTTING MARKET OVERVIEW    60
FIGURE 14    TECHNOLOGICAL ADVANCEMENTS AND GROWING DEMAND FOR PERSONALIZED MEDICINE ARE KEY FACTORS DRIVING GROWTH IN
THE WESTERN BLOTTING MARKET    60
4.2    ASIA PACIFIC: WESTERN BLOTTING MARKET, BY END USER & COUNTRY (2020)    61
FIGURE 15    ACADEMIC & RESEARCH INSTITUTES ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2020    61
4.3    WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE, 2020    61
FIGURE 16    THE BLOTTING SYSTEMS SEGMENT DOMINATED THE MARKET IN 2020    61
4.4    WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2020    62
FIGURE 17    THE SEMI-DRY BLOTTING SYSTEMS SEGMENT IS PROJECTED TO WITNESS
THE HIGHEST GROWTH DURING THE FORECAST PERIOD    62
4.5    WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS, BY TYPE, 2020    62
FIGURE 18    THE CHEMILUMINESCENT IMAGERS SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE WESTERN BLOTTING MARKET IN 2020    62
5    MARKET OVERVIEW    63
5.1    INTRODUCTION    63
5.2    MARKET DYNAMICS    63
FIGURE 19    WESTERN BLOTTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES    63
5.2.1    DRIVERS    64
5.2.1.1    Technological advancements    64
5.2.1.2    Increasing government funding in the field of biomedical research    64
5.2.1.3    Growing demand for personalized medicine    65
FIGURE 20    NUMBER OF PERSONALIZED MEDICINES IN THE MARKET, 2008–2020    65
5.2.1.4    Rising global prevalence and incidence of HIV/AIDS    66
TABLE 1    INCIDENCE OF HIV/AIDS, BY REGION, 2020    66
5.2.2    RESTRAINTS    67
5.2.2.1    Emergence of alternative technologies    67
5.2.3    OPPORTUNITIES    67
5.2.3.1    Emerging economies    67
5.2.4    CHALLENGES    68
5.2.4.1    Requirement of high procedural efficiency for accurate results    68
5.3    IMPACT OF COVID-19 ON THE WESTERN BLOTTING MARKET    69
5.4    PATENT ANALYSIS    70
5.4.1    NUMBER OF PUBLICATIONS OVER THE LAST 10 YEARS    70
5.4.2    TOP 10 GRANTED PATENT OWNERS IN THE LAST 20 YEARS    70
5.4.3    TOP 10 PLAYERS WITH THE HIGHEST NO. OF PATENT APPLICATIONS    71
5.4.4    LIST OF RECENT PATENTS    71
5.5    REGULATORY GUIDELINES    72
5.5.1    NORTH AMERICA    72
5.5.2    EUROPE    72
5.5.3    EMERGING MARKETS    72
5.6    VALUE CHAIN ANALYSIS    73
FIGURE 21    VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASES    73
5.7    SUPPLY CHAIN ANALYSIS    74
FIGURE 22    DIRECT DISTRIBUTION—THE PREFERRED STRATEGY FOR PROMINENT COMPANIES    75
5.8    PORTER’S FIVE FORCES ANALYSIS    75
TABLE 2    WESTERN BLOTTING MARKET: PORTER’S FIVE FORCES ANALYSIS    75
5.8.1    DEGREE OF COMPETITION    75
5.8.2    BARGAINING POWER OF SUPPLIERS    76
5.8.3    BARGAINING POWER OF BUYERS    76
5.8.4    THREAT FROM SUBSTITUTES    76
5.8.5    THREAT FROM NEW ENTRANTS    76
5.9    ECOSYSTEM ANALYSIS OF THE WESTERN BLOTTING MARKET    77
FIGURE 23    ECOSYSTEM ANALYSIS OF THE WESTERN BLOTTING MARKET    77
5.9.1    ROLE IN THE ECOSYSTEM    77
5.10    TECHNOLOGY ANALYSIS    78
5.10.1    ALTERNATIVES TO TRADITIONAL WESTERN BLOTTING    78
5.11    RANGES/SCENARIOS    79
FIGURE 24    DEPENDING ON HOW THE UNCERTAINTIES UNFOLD, WE SEE A SPECTRUM OF SCENARIOS FOR THE WESTERN BLOTTING MARKET    79
5.12    TRADE ANALYSIS    80
5.12.1    TRADE ANALYSIS FOR WESTERN BLOTTING    80
TABLE 3    IMPORT DATA FOR HS CODE 90278090, BY COUNTRY,
2016–2020 (USD MILLION)    80
TABLE 4    EXPORT DATA FOR HS CODE 90278090, BY COUNTRY,
2016–2020 (USD MILLION)    80
5.13    TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS    81
6    WESTERN BLOTTING MARKET, BY PRODUCT    82
6.1    INTRODUCTION    83
TABLE 5    WESTERN BLOTTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)    83
6.2    CONSUMABLES    83
TABLE 6    WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION)    83
TABLE 7    WESTERN BLOTTING CONSUMABLES MARKET, BY REGION,
2019–2026 (USD MILLION)    84
TABLE 8    NORTH AMERICA: WESTERN BLOTTING CONSUMABLES MARKET,
BY COUNTRY, 2019–2026 (USD MILLION)    84
TABLE 9    EUROPE: WESTERN BLOTTING CONSUMABLES MARKET, BY COUNTRY,
2019–2026 (USD MILLION)    84
TABLE 10    APAC: WESTERN BLOTTING CONSUMABLES MARKET, BY COUNTRY,
2019–2026 (USD MILLION)    85
6.2.1    REAGENTS & BUFFERS    85
6.2.1.1    High consumption of reagents & buffers during the western blot process to drive market growth    85
TABLE 11    WESTERN BLOTTING MARKET FOR REAGENTS & BUFFERS, BY REGION, 2019–2026 (USD MILLION)    86
TABLE 12    NORTH AMERICA: WESTERN BLOTTING MARKET FOR REAGENTS & BUFFERS, BY COUNTRY, 2019–2026 (USD MILLION)    86
TABLE 13    EUROPE: WESTERN BLOTTING MARKET FOR REAGENTS & BUFFERS,
BY COUNTRY, 2019–2026 (USD MILLION)    87
TABLE 14    APAC: WESTERN BLOTTING MARKET FOR REAGENTS & BUFFERS,
BY COUNTRY, 2019–2026 (USD MILLION)    87
6.2.2    ANTIBODIES & CONJUGATES    87
TABLE 15    WESTERN BLOTTING MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019–2026 (USD MILLION)    87
TABLE 16    WESTERN BLOTTING MARKET FOR ANTIBODIES & CONJUGATES, BY REGION, 2019–2026 (USD MILLION)    88
TABLE 17    NORTH AMERICA: WESTERN BLOTTING MARKET FOR ANTIBODIES & CONJUGATES, BY COUNTRY, 2019–2026 (USD MILLION)    88
TABLE 18    EUROPE: WESTERN BLOTTING MARKET FOR ANTIBODIES & CONJUGATES,
BY COUNTRY, 2019–2026 (USD MILLION)    88
TABLE 19    APAC: WESTERN BLOTTING MARKET FOR ANTIBODIES & CONJUGATES,
BY COUNTRY, 2019–2026 (USD MILLION)    89
6.2.2.1    Primary antibodies    89
6.2.2.1.1    Primary antibodies are mainly used to recognize a specific protein of interest    89
TABLE 20    WESTERN BLOTTING MARKET FOR PRIMARY ANTIBODIES, BY REGION,
2019–2026 (USD MILLION)    89
TABLE 21    NORTH AMERICA: WESTERN BLOTTING MARKET FOR PRIMARY ANTIBODIES, BY COUNTRY, 2019–2026 (USD MILLION)    90
TABLE 22    EUROPE: WESTERN BLOTTING MARKET FOR PRIMARY ANTIBODIES,
BY COUNTRY, 2019–2026 (USD MILLION)    90
TABLE 23    APAC: WESTERN BLOTTING MARKET FOR PRIMARY ANTIBODIES,
BY COUNTRY, 2019–2026 (USD MILLION)    90
6.2.2.2    Secondary antibodies    91
6.2.2.2.1    High sensitivity of secondary antibodies makes it easier to detect proteins of interest in complex protein mixtures    91
TABLE 24    WESTERN BLOTTING MARKET FOR SECONDARY ANTIBODIES, BY REGION, 2019–2026 (USD MILLION)    91
TABLE 25    NORTH AMERICA: WESTERN BLOTTING MARKET FOR SECONDARY ANTIBODIES, BY COUNTRY, 2019–2026 (USD MILLION)    91
TABLE 26    EUROPE: WESTERN BLOTTING MARKET FOR SECONDARY ANTIBODIES,
BY COUNTRY, 2019–2026 (USD MILLION)    92
TABLE 27    APAC: WESTERN BLOTTING MARKET FOR SECONDARY ANTIBODIES,
BY COUNTRY, 2019–2026 (USD MILLION)    92
6.2.2.3    Other antibodies & conjugates    92
TABLE 28    WESTERN BLOTTING MARKET FOR OTHER ANTIBODIES & CONJUGATES,
BY REGION, 2019–2026 (USD MILLION)    93
TABLE 29    NORTH AMERICA: WESTERN BLOTTING MARKET FOR OTHER ANTIBODIES & CONJUGATES, BY COUNTRY, 2019–2026 (USD MILLION)    93
TABLE 30    EUROPE: WESTERN BLOTTING MARKET FOR OTHER ANTIBODIES & CONJUGATES, BY COUNTRY, 2019–2026 (USD MILLION)    93
TABLE 31    APAC: WESTERN BLOTTING MARKET FOR OTHER ANTIBODIES & CONJUGATES, BY COUNTRY, 2019–2026 (USD MILLION)    94
6.2.3    KITS    94
6.2.3.1    Repeat purchases of single-use ready-to-use kits to drive market growth    94
TABLE 32    WESTERN BLOTTING MARKET FOR KITS, BY REGION,
2019–2026 (USD MILLION)    94
TABLE 33    NORTH AMERICA: WESTERN BLOTTING MARKET FOR KITS, BY COUNTRY, 2019–2026 (USD MILLION)    95
TABLE 34    EUROPE: WESTERN BLOTTING MARKET FOR KITS, BY COUNTRY,
2019–2026 (USD MILLION)    95
TABLE 35    APAC: WESTERN BLOTTING MARKET FOR KITS, BY COUNTRY,
2019–2026 (USD MILLION)    95
6.2.4    MEMBRANES & FILTER PAPERS    96
6.2.4.1    Extensive usage of membranes & filter papers to support the immobilization and transfer steps during western blotting experiments to drive market growth    96
TABLE 36    COMPARISON OF NITROCELLULOSE MEMBRANES AND PVDF MEMBRANES    96
TABLE 37    WESTERN BLOTTING MARKET FOR MEMBRANES & FILTER PAPERS,
BY REGION, 2019–2026 (USD MILLION)    97
TABLE 38    NORTH AMERICA: WESTERN BLOTTING MARKET FOR MEMBRANES & FILTER PAPERS, BY COUNTRY, 2019–2026 (USD MILLION)    97
TABLE 39    EUROPE: WESTERN BLOTTING MARKET FOR MEMBRANES & FILTER PAPERS, BY COUNTRY, 2019–2026 (USD MILLION)    97
TABLE 40    APAC: WESTERN BLOTTING MARKET FOR MEMBRANES & FILTER PAPERS,
BY COUNTRY, 2019–2026 (USD MILLION)    98
6.2.5    OTHER CONSUMABLES    98
TABLE 41    WESTERN BLOTTING MARKET FOR OTHER CONSUMABLES, BY REGION, 2019–2026 (USD MILLION)    98
TABLE 42    NORTH AMERICA: WESTERN BLOTTING MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2019–2026 (USD MILLION)    99
TABLE 43    EUROPE: WESTERN BLOTTING MARKET FOR OTHER CONSUMABLES,
BY COUNTRY, 2019–2026 (USD MILLION)    99
TABLE 44    APAC: WESTERN BLOTTING MARKET FOR OTHER CONSUMABLES,
BY COUNTRY, 2019–2026 (USD MILLION)    99
6.3    INSTRUMENTS    100
TABLE 45    WESTERN BLOTTING INSTRUMENTS MARKET, BY REGION,
2019–2026 (USD MILLION)    100
TABLE 46    NORTH AMERICA: WESTERN BLOTTING INSTRUMENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)    100
TABLE 47    EUROPE: WESTERN BLOTTING INSTRUMENTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION)    101
TABLE 48    APAC: WESTERN BLOTTING INSTRUMENTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION)    101
TABLE 49    WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)    101

6.3.1    GEL ELECTROPHORESIS INSTRUMENTS    102
6.3.1.1    Increased demand for 2D electrophoresis due to its high separation performance is one of the major factors driving the growth of
the market    102
TABLE 50    WESTERN BLOTTING MARKET FOR GEL ELECTROPHORESIS INSTRUMENTS, BY REGION, 2019–2026 (USD MILLION)    102
TABLE 51    NORTH AMERICA: WESTERN BLOTTING MARKET FOR GEL ELECTROPHORESIS INSTRUMENTS, BY COUNTRY, 2019–2026 (USD MILLION)    103
TABLE 52    EUROPE: WESTERN BLOTTING MARKET FOR GEL ELECTROPHORESIS INSTRUMENTS, BY COUNTRY, 2019–2026 (USD MILLION)    103
TABLE 53    APAC: WESTERN BLOTTING MARKET FOR GEL ELECTROPHORESIS INSTRUMENTS, BY COUNTRY, 2019–2026 (USD MILLION)    103
6.3.2    BLOTTING SYSTEMS    104
TABLE 54    COMPARISON BETWEEN PROTEIN BLOTTING SYSTEMS    104
TABLE 55    WESTERN BLOTTING MARKET FOR BLOTTING SYSTEMS, BY TYPE,
2019–2026 (USD MILLION)    104
TABLE 56    WESTERN BLOTTING MARKET FOR BLOTTING SYSTEMS, BY REGION,
2019–2026 (USD MILLION)    105
TABLE 57    NORTH AMERICA: WESTERN BLOTTING MARKET FOR BLOTTING SYSTEMS,
BY COUNTRY, 2019–2026 (USD MILLION)    105
TABLE 58    EUROPE: WESTERN BLOTTING MARKET FOR BLOTTING SYSTEMS,
BY COUNTRY, 2019–2026 (USD MILLION)    105
TABLE 59    APAC: WESTERN BLOTTING MARKET FOR BLOTTING SYSTEMS, BY COUNTRY, 2019–2026 (USD MILLION)    106
6.3.2.1    Wet blotting systems    106
6.3.2.1.1    Wet systems are most commonly used for the transfer of proteins from gels to membranes    106
TABLE 60    WESTERN BLOTTING MARKET FOR WET BLOTTING SYSTEMS, BY REGION, 2019–2026 (USD MILLION)    106
TABLE 61    NORTH AMERICA: WESTERN BLOTTING MARKET FOR WET BLOTTING SYSTEMS, BY COUNTRY, 2019–2026 (USD MILLION)    107
TABLE 62    EUROPE: WESTERN BLOTTING MARKET FOR WET BLOTTING SYSTEMS,
BY COUNTRY, 2019–2026 (USD MILLION)    107
TABLE 63    APAC: WESTERN BLOTTING MARKET FOR WET BLOTTING SYSTEMS,
BY COUNTRY, 2019–2026 (USD MILLION)    107
6.3.2.2    Semi-dry blotting systems    108
6.3.2.2.1    Minimal usage of buffers during the process and rapid transfer of proteins from gels to membranes are major factors driving the demand for semi-dry blotting systems    108
TABLE 64    WESTERN BLOTTING MARKET FOR SEMI-DRY BLOTTING SYSTEMS, BY REGION, 2019–2026 (USD MILLION)    108
TABLE 65    NORTH AMERICA: WESTERN BLOTTING MARKET FOR SEMI-DRY BLOTTING SYSTEMS, BY COUNTRY, 2019–2026 (USD MILLION)    108
TABLE 66    EUROPE: WESTERN BLOTTING MARKET FOR SEMI-DRY BLOTTING SYSTEMS, BY COUNTRY, 2019–2026 (USD MILLION)    109
TABLE 67    APAC: WESTERN BLOTTING MARKET FOR SEMI-DRY BLOTTING SYSTEMS,
BY COUNTRY, 2019–2026 (USD MILLION)    109

6.3.3    IMAGERS    109
TABLE 68    WESTERN BLOTTING MARKET FOR IMAGERS, BY TYPE,
2019–2026 (USD MILLION)    110
TABLE 69    WESTERN BLOTTING MARKET FOR IMAGERS, BY REGION,
2019–2026 (USD MILLION)    110
TABLE 70    NORTH AMERICA: WESTERN BLOTTING MARKET FOR IMAGERS, BY COUNTRY, 2019–2026 (USD MILLION)    110
TABLE 71    EUROPE: WESTERN BLOTTING MARKET FOR IMAGERS, BY COUNTRY,
2019–2026 (USD MILLION)    111
TABLE 72    APAC: WESTERN BLOTTING MARKET FOR IMAGERS, BY COUNTRY,
2019–2026 (USD MILLION)    111
6.3.3.1    Chemiluminescent imagers    111
6.3.3.1.1    Low cost of these imagers, easy handling, and sensitivity are some of the key factors contributing to the large share of this market    111
TABLE 73    WESTERN BLOTTING MARKET FOR CHEMILUMINESCENT IMAGERS,
BY REGION, 2019–2026 (USD MILLION)    112
TABLE 74    NORTH AMERICA: WESTERN BLOTTING MARKET FOR CHEMILUMINESCENT IMAGERS, BY COUNTRY, 2019–2026 (USD MILLION)    112
TABLE 75    EUROPE: WESTERN BLOTTING MARKET FOR CHEMILUMINESCENT IMAGERS, BY COUNTRY, 2019–2026 (USD MILLION)    112
TABLE 76    APAC: WESTERN BLOTTING MARKET FOR CHEMILUMINESCENT IMAGERS,
BY COUNTRY, 2019–2026 (USD MILLION)    113
6.3.3.2    Fluorescent imagers    113
6.3.3.2.1    Fluorescent imagers serve as one-stop imaging systems as they avoid multiple film exposures and development steps    113
TABLE 77    WESTERN BLOTTING MARKET FOR FLUORESCENT IMAGERS, BY REGION, 2019–2026 (USD MILLION)    113
TABLE 78    NORTH AMERICA: WESTERN BLOTTING MARKET FOR FLUORESCENT IMAGERS, BY COUNTRY, 2019–2026 (USD MILLION)    114
TABLE 79    EUROPE: WESTERN BLOTTING MARKET FOR FLUORESCENT IMAGERS,
BY COUNTRY, 2019–2026 (USD MILLION)    114
TABLE 80    APAC: WESTERN BLOTTING MARKET FOR FLUORESCENT IMAGERS,
BY COUNTRY, 2019–2026 (USD MILLION)    114
6.3.3.3    Other imagers    115
TABLE 81    WESTERN BLOTTING MARKET FOR OTHER IMAGERS, BY REGION,
2019–2026 (USD MILLION)    115
TABLE 82    NORTH AMERICA: WESTERN BLOTTING MARKET FOR OTHER IMAGERS,
BY COUNTRY, 2019–2026 (USD MILLION)    115
TABLE 83    EUROPE: WESTERN BLOTTING MARKET FOR OTHER IMAGERS, BY COUNTRY, 2019–2026 (USD MILLION)    116
TABLE 84    APAC: WESTERN BLOTTING MARKET FOR OTHER IMAGERS, BY COUNTRY, 2019–2026 (USD MILLION)    116

7    WESTERN BLOTTING MARKET, BY APPLICATION    117
7.1    INTRODUCTION    118
TABLE 85    WESTERN BLOTTING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)    118
7.2    BIOMEDICAL RESEARCH    118
7.2.1    INCREASING RESEARCH FUNDING FOR PROTEOMICS AND PROTEIN-BASED RESEARCH—A MAJOR DRIVER FOR THIS APPLICATION SEGMENT    118
TABLE 86    WESTERN BLOTTING MARKET FOR BIOMEDICAL RESEARCH APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)    119
TABLE 87    NORTH AMERICA: WESTERN BLOTTING MARKET FOR BIOMEDICAL RESEARCH APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)    119
TABLE 88    EUROPE: WESTERN BLOTTING MARKET FOR BIOMEDICAL RESEARCH APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)    119
TABLE 89    APAC: WESTERN BLOTTING MARKET FOR BIOMEDICAL RESEARCH APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)    120
7.3    CLINICAL DIAGNOSTICS    120
TABLE 90    WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS,
BY REGION, 2019–2026 (USD MILLION)    120
TABLE 91    NORTH AMERICA: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)    121
TABLE 92    EUROPE: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)    121
TABLE 93    APAC: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)    121
TABLE 94    WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS,
BY DISEASE TYPE, 2019–2026 (USD MILLION)    122
7.3.1    HIV    122
7.3.1.1    Western blotting is the most widely used method for HIV diagnosis—
a key factor driving market growth    122
TABLE 95    WESTERN BLOTTING MARKET FOR HIV DIAGNOSIS, BY REGION,
2019–2026 (USD MILLION)    122
TABLE 96    NORTH AMERICA: WESTERN BLOTTING MARKET FOR HIV DIAGNOSIS,
BY COUNTRY, 2019–2026 (USD MILLION)    123
TABLE 97    EUROPE: WESTERN BLOTTING MARKET FOR HIV DIAGNOSIS, BY COUNTRY, 2019–2026 (USD MILLION)    123
TABLE 98    APAC: WESTERN BLOTTING MARKET FOR HIV DIAGNOSIS, BY COUNTRY, 2019–2026 (USD MILLION)    123
7.3.2    HEPATITIS    124
7.3.2.1    Growing incidence of hepatitis C to drive market growth    124
TABLE 99    WESTERN BLOTTING MARKET FOR HEPATITIS DIAGNOSIS, BY REGION,
2019–2026 (USD MILLION)    124
TABLE 100    NORTH AMERICA: WESTERN BLOTTING MARKET FOR HEPATITIS DIAGNOSIS, BY COUNTRY, 2019–2026 (USD MILLION)    124
TABLE 101    EUROPE: WESTERN BLOTTING MARKET FOR HEPATITIS DIAGNOSIS,
BY COUNTRY, 2019–2026 (USD MILLION)    125
TABLE 102    APAC: WESTERN BLOTTING MARKET FOR HEPATITIS DIAGNOSIS,
BY COUNTRY, 2019–2026 (USD MILLION)    125

7.3.3    LYME DISEASE    125
7.3.3.1    Western blots are generally considered the most reliable tests currently available for Lyme disease diagnosis    125
TABLE 103    WESTERN BLOTTING MARKET FOR LYME DISEASE DIAGNOSIS, BY REGION, 2019–2026 (USD MILLION)    126
TABLE 104    NORTH AMERICA: WESTERN BLOTTING MARKET FOR LYME DISEASE DIAGNOSIS, BY COUNTRY, 2019–2026 (USD MILLION)    126
TABLE 105    EUROPE: WESTERN BLOTTING MARKET FOR LYME DISEASE DIAGNOSIS,
BY COUNTRY, 2019–2026 (USD MILLION)    126
TABLE 106    APAC: WESTERN BLOTTING MARKET FOR LYME DISEASE DIAGNOSIS,
BY COUNTRY, 2019–2026 (USD MILLION)    127
7.3.4    OTHER DISEASES    127
TABLE 107    WESTERN BLOTTING MARKET FOR OTHER DISEASES, BY REGION,
2019–2026 (USD MILLION)    127
TABLE 108    NORTH AMERICA: WESTERN BLOTTING MARKET FOR OTHER DISEASES,
BY COUNTRY, 2019–2026 (USD MILLION)    128
TABLE 109    EUROPE: WESTERN BLOTTING MARKET FOR OTHER DISEASES, BY COUNTRY, 2019–2026 (USD MILLION)    128
TABLE 110    APAC: WESTERN BLOTTING MARKET FOR OTHER DISEASES, BY COUNTRY, 2019–2026 (USD MILLION)    128
7.4    AGRICULTURAL APPLICATIONS    129
7.4.1    GROWING CULTIVATION OF GENETICALLY MODIFIED CROPS TO DRIVE MARKET GROWTH    129
TABLE 111    WESTERN BLOTTING MARKET FOR AGRICULTURAL APPLICATIONS,
BY REGION, 2019–2026 (USD MILLION)    129
TABLE 112    NORTH AMERICA: WESTERN BLOTTING MARKET FOR AGRICULTURAL APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)    129
TABLE 113    EUROPE: WESTERN BLOTTING MARKET FOR AGRICULTURAL APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)    130
TABLE 114    APAC: WESTERN BLOTTING MARKET FOR AGRICULTURAL APPLICATIONS,
BY COUNTRY, 2019–2026 (USD MILLION)    130
7.5    OTHER APPLICATIONS    130
TABLE 115    WESTERN BLOTTING MARKET FOR OTHER APPLICATIONS, BY REGION,
2019–2026 (USD MILLION)    131
TABLE 116    NORTH AMERICA: WESTERN BLOTTING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)    131
TABLE 117    EUROPE: WESTERN BLOTTING MARKET FOR OTHER APPLICATIONS,
 BY COUNTRY, 2019–2026 (USD MILLION)    131
TABLE 118    APAC: WESTERN BLOTTING MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2019–2026 (USD MILLION)    132
8    WESTERN BLOTTING MARKET, BY END USER    133
8.1    INTRODUCTION    134
TABLE 119    WESTERN BLOTTING MARKET, BY END USER, 2019–2026 (USD MILLION)    134
8.2    ACADEMIC & RESEARCH INSTITUTES    134
8.2.1    INCREASING GOVERNMENT INVESTMENTS FOR RESEARCH ACTIVITIES TO DRIVE GROWTH IN THIS MARKET SEGMENT    134
TABLE 120    WESTERN BLOTTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES,
BY REGION, 2019–2026 (USD MILLION)    135
TABLE 121    NORTH AMERICA: WESTERN BLOTTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION)    135
TABLE 122    EUROPE: WESTERN BLOTTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION)    135
TABLE 123    APAC: WESTERN BLOTTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION)    136
8.3    BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES    136
8.3.1    GROWING DRUG DISCOVERY AND CLINICAL STUDIES TO DRIVE THE DEMAND FOR WESTERN BLOTTING IN THE PHARMA-BIOTECH INDUSTRY    136
TABLE 124    WESTERN BLOTTING MARKET FOR BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2019–2026 (USD MILLION)    137
TABLE 125    NORTH AMERICA: WESTERN BLOTTING MARKET FOR BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION)    137
TABLE 126    EUROPE: WESTERN BLOTTING MARKET FOR BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION)    137
TABLE 127    APAC: WESTERN BLOTTING MARKET FOR BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION)    138
8.4    HOSPITALS & DIAGNOSTIC LABORATORIES    138
8.4.1    GROWING PATIENT POPULATION AND TESTING VOLUMES TO DRIVE MARKET GROWTH    138
TABLE 128    WESTERN BLOTTING MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2019–2026 (USD MILLION)    139
TABLE 129    NORTH AMERICA: WESTERN BLOTTING MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION)    139
TABLE 130    EUROPE: WESTERN BLOTTING MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION)    140
TABLE 131    APAC: WESTERN BLOTTING FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION)    140
8.5    OTHER END USERS    140
TABLE 132    WESTERN BLOTTING MARKET FOR OTHER END USERS, BY REGION,
2019–2026 (USD MILLION)    141
TABLE 133    NORTH AMERICA: WESTERN BLOTTING MARKET FOR OTHER END USERS,
BY COUNTRY, 2019–2026 (USD MILLION)    141
TABLE 134    EUROPE: WESTERN BLOTTING MARKET FOR OTHER END USERS,
BY COUNTRY, 2019–2026 (USD MILLION)    141
TABLE 135    APAC: WESTERN BLOTTING MARKET FOR OTHER END USERS, BY COUNTRY, 2019–2026 (USD MILLION)    142
9    WESTERN BLOTTING MARKET, BY REGION    143
9.1    INTRODUCTION    144
9.2    NORTH AMERICA    144
FIGURE 25    NORTH AMERICA: WESTERN BLOTTING MARKET SNAPSHOT    144
TABLE 136    NORTH AMERICA: WESTERN BLOTTING MARKET, BY COUNTRY,
2019–2026 (USD MILLION)    145
TABLE 137    NORTH AMERICA: WESTERN BLOTTING MARKET, BY PRODUCT,
2019–2026 (USD MILLION)    145
TABLE 138    NORTH AMERICA: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)    145
TABLE 139    NORTH AMERICA: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019–2026 (USD MILLION)    145
TABLE 140    NORTH AMERICA: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS, BY TYPE, 2019–2026 (USD MILLION)    146
TABLE 141    NORTH AMERICA: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)    146
TABLE 142    NORTH AMERICA: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019–2026 (USD MILLION)    146
TABLE 143    NORTH AMERICA: WESTERN BLOTTING MARKET, BY APPLICATION,
2019–2026 (USD MILLION)    147
TABLE 144    NORTH AMERICA: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019–2026 (USD MILLION)    147
TABLE 145    NORTH AMERICA: WESTERN BLOTTING MARKET, BY END USER,
2019–2026 (USD MILLION)    147
9.2.1    US    148
9.2.1.1    The US dominates the North American western blotting market    148
TABLE 146    US: WESTERN BLOTTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)    148
TABLE 147    US: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)    148
TABLE 148    US: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019–2026 (USD MILLION)    149
TABLE 149    US: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS, BY TYPE, 2019–2026 (USD MILLION)    149
TABLE 150    US: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION)    149
TABLE 151    US: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019–2026 (USD MILLION)    150
TABLE 152    US: WESTERN BLOTTING MARKET, BY APPLICATION,
2019–2026 (USD MILLION)    150
TABLE 153    US: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019–2026 (USD MILLION)    150
TABLE 154    US: WESTERN BLOTTING MARKET, BY END USER, 2019–2026 (USD MILLION)    151
9.2.2    CANADA    151
9.2.2.1    Strong infrastructure and availability of funding for biomedical research to support market growth in Canada    151
TABLE 155    CANADA: WESTERN BLOTTING MARKET, BY PRODUCT,
2019–2026 (USD MILLION)    152
TABLE 156    CANADA: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)    152
TABLE 157    CANADA: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019–2026 (USD MILLION)    152
TABLE 158    CANADA: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS,
BY TYPE, 2019–2026 (USD MILLION)    152
TABLE 159    CANADA: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION)    153
TABLE 160    CANADA: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019–2026 (USD MILLION)    153
TABLE 161    CANADA: WESTERN BLOTTING MARKET, BY APPLICATION,
2019–2026 (USD MILLION)    153
TABLE 162    CANADA: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019–2026 (USD MILLION)    154
TABLE 163    CANADA: WESTERN BLOTTING MARKET, BY END USER,
2019–2026 (USD MILLION)    154
9.3    EUROPE    154
TABLE 164    EUROPE: WESTERN BLOTTING MARKET, BY COUNTRY,
2019–2026 (USD MILLION)    155
TABLE 165    EUROPE: WESTERN BLOTTING MARKET, BY PRODUCT,
2019–2026 (USD MILLION)    155
TABLE 166    EUROPE: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)    155
TABLE 167    EUROPE: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019–2026 (USD MILLION)    156
TABLE 168    EUROPE: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS,
BY TYPE, 2019–2026 (USD MILLION)    156
TABLE 169    EUROPE: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION)    156
TABLE 170    EUROPE: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019–2026 (USD MILLION)    157
TABLE 171    EUROPE: WESTERN BLOTTING MARKET, BY APPLICATION,
2019–2026 (USD MILLION)    157
TABLE 172    EUROPE: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019–2026 (USD MILLION)    157
TABLE 173    EUROPE: WESTERN BLOTTING MARKET, BY END USER,
2019–2026 (USD MILLION)    158
9.3.1    GERMANY    158
9.3.1.1    Germany is the largest market for western blotting in Europe    158
TABLE 174    GERMANY: WESTERN BLOTTING MARKET, BY PRODUCT,
2019–2026 (USD MILLION)    159
TABLE 175    GERMANY: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)    159
TABLE 176    GERMANY: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019–2026 (USD MILLION)    159
TABLE 177    GERMANY: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS MARKET, BY TYPE, 2019–2026 (USD MILLION)    160
TABLE 178    GERMANY: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION)    160
TABLE 179    GERMANY: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019–2026 (USD MILLION)    160
TABLE 180    GERMANY: WESTERN BLOTTING MARKET, BY APPLICATION,
2019–2026 (USD MILLION)    161
TABLE 181    GERMANY: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019–2026 (USD MILLION)    161
TABLE 182    GERMANY: WESTERN BLOTTING MARKET, BY END USER,
2019–2026 (USD MILLION)    161

9.3.2    FRANCE    162
9.3.2.1    Proteomics research in France is strongly supported
by the government—a key factor driving market growth    162
TABLE 183    FRANCE: WESTERN BLOTTING MARKET, BY PRODUCT,
2019–2026 (USD MILLION)    162
TABLE 184    FRANCE: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)    163
TABLE 185    FRANCE: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019–2026 (USD MILLION)    163
TABLE 186    FRANCE: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS,
BY TYPE, 2019–2026 (USD MILLION)    163
TABLE 187    FRANCE: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION)    164
TABLE 188    FRANCE: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019–2026 (USD MILLION)    164
TABLE 189    FRANCE: WESTERN BLOTTING MARKET, BY APPLICATION,
2019–2026 (USD MILLION)    164
TABLE 190    FRANCE: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019–2026 (USD MILLION)    165
TABLE 191    FRANCE: WESTERN BLOTTING MARKET, BY END USER,
2019–2026 (USD MILLION)    165
9.3.3    UK    165
9.3.3.1    Government support for disease diagnostics and the favorable investment scenario to drive the market in the UK    165
TABLE 192    UK: WESTERN BLOTTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)    166
TABLE 193    UK: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)    166
TABLE 194    UK: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019–2026 (USD MILLION)    167
TABLE 195    UK: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS, BY TYPE, 2019–2026 (USD MILLION)    167
TABLE 196    UK: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION)    167
TABLE 197    UK: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019–2026 (USD MILLION)    168
TABLE 198    UK: WESTERN BLOTTING MARKET, BY APPLICATION,
2019–2026 (USD MILLION)    168
TABLE 199    UK: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019–2026 (USD MILLION)    168
TABLE 200    UK: WESTERN BLOTTING MARKET, BY END USER, 2019–2026 (USD MILLION)    169
9.3.4    ITALY    169
9.3.4.1    Growth in this market is mainly driven by increasing life science R&D in the country    169
TABLE 201    ITALY: WESTERN BLOTTING MARKET, BY PRODUCT,
2019–2026 (USD MILLION)    170
TABLE 202    ITALY: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)    170
TABLE 203    ITALY: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019–2026 (USD MILLION)    170
TABLE 204    ITALY: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS, BY TYPE, 2019–2026 (USD MILLION)    171
TABLE 205    ITALY: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION)    171
TABLE 206    ITALY: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019–2026 (USD MILLION)    171
TABLE 207    ITALY: WESTERN BLOTTING MARKET, BY APPLICATION,
2019–2026 (USD MILLION)    172
TABLE 208    ITALY: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019–2026 (USD MILLION)    172
TABLE 209    ITALY: WESTERN BLOTTING MARKET, BY END USER,
2019–2026 (USD MILLION)    172
9.3.5    SPAIN    173
9.3.5.1    Well-established network for translational medicine research to drive market growth in Spain    173
TABLE 210    SPAIN: WESTERN BLOTTING MARKET, BY PRODUCT,
2019–2026 (USD MILLION)    173
TABLE 211    SPAIN: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)    174
TABLE 212    SPAIN: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019–2026 (USD MILLION)    174
TABLE 213    SPAIN: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS, BY TYPE, 2019–2026 (USD MILLION)    174
TABLE 214    SPAIN: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION)    175
TABLE 215    SPAIN: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019–2026 (USD MILLION)    175
TABLE 216    SPAIN: WESTERN BLOTTING MARKET, BY APPLICATION,
2019–2026 (USD MILLION)    175
TABLE 217    SPAIN: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019–2026 (USD MILLION)    176
TABLE 218    SPAIN: WESTERN BLOTTING MARKET, BY END USER,
2019–2026 (USD MILLION)    176
9.3.6    REST OF EUROPE (ROE)    176
TABLE 219    ROE: WESTERN BLOTTING MARKET, BY PRODUCT,
2019–2026 (USD MILLION)    177
TABLE 220    ROE: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)    177
TABLE 221    ROE: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019–2026 (USD MILLION)    178
TABLE 222    ROE: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS, BY TYPE, 2019–2026 (USD MILLION)    178
TABLE 223    ROE: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION)    178
TABLE 224    ROE: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019–2026 (USD MILLION)    179
TABLE 225    ROE: WESTERN BLOTTING MARKET, BY APPLICATION,
2019–2026 (USD MILLION)    179
TABLE 226    ROE: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019–2026 (USD MILLION)    179
TABLE 227    ROE: WESTERN BLOTTING MARKET, BY END USER,
2019–2026 (USD MILLION)    180"
"9.4    ASIA PACIFIC    181
FIGURE 26    ASIA PACIFIC: WESTERN BLOTTING MARKET SNAPSHOT    181
TABLE 228    APAC: WESTERN BLOTTING MARKET, BY COUNTRY,
2019–2026 (USD MILLION)    182
TABLE 229    APAC: WESTERN BLOTTING MARKET, BY PRODUCT,
2019–2026 (USD MILLION)    182
TABLE 230    APAC: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)    182
TABLE 231    APAC: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019–2026 (USD MILLION)    183
TABLE 232    APAC: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS, BY TYPE, 2019–2026 (USD MILLION)    183
TABLE 233    APAC: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION)    183
TABLE 234    APAC: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019–2026 (USD MILLION)    184
TABLE 235    APAC: WESTERN BLOTTING MARKET, BY APPLICATION,
2019–2026 (USD MILLION)    184
TABLE 236    APAC: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019–2026 (USD MILLION)    184
TABLE 237    APAC: WESTERN BLOTTING MARKET, BY END USER,
2019–2026 (USD MILLION)    185
9.4.1    JAPAN    185
9.4.1.1    Growing research initiatives towards the development of precision medicine are supporting market growth in Japan    185
TABLE 238    JAPAN: WESTERN BLOTTING MARKET, BY PRODUCT,
2019–2026 (USD MILLION)    186
TABLE 239    JAPAN: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)    186
TABLE 240    JAPAN: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019–2026 (USD MILLION)    186
TABLE 241    JAPAN: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS, BY TYPE, 2019–2026 (USD MILLION)    186
TABLE 242    JAPAN: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION)    187
TABLE 243    JAPAN: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019–2026 (USD MILLION)    187
TABLE 244    JAPAN: WESTERN BLOTTING MARKET, BY APPLICATION,
2019–2026 (USD MILLION)    187
TABLE 245    JAPAN: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019–2026 (USD MILLION)    188
TABLE 246    JAPAN: WESTERN BLOTTING MARKET, BY END USER,
2019–2026 (USD MILLION)    188

9.4.2    CHINA    188
9.4.2.1    Increasing government support for the biomedical and biotechnology industries to drive market growth    188
TABLE 247    CHINA: WESTERN BLOTTING MARKET, BY PRODUCT,
2019–2026 (USD MILLION)    189
TABLE 248    CHINA: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)    189
TABLE 249    CHINA: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019–2026 (USD MILLION)    189
TABLE 250    CHINA: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS, BY TYPE, 2019–2026 (USD MILLION)    190
TABLE 251    CHINA: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION)    190
TABLE 252    CHINA: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019–2026 (USD MILLION)    190
TABLE 253    CHINA: WESTERN BLOTTING MARKET, BY APPLICATION,
2019–2026 (USD MILLION)    191
TABLE 254    CHINA: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019–2026 (USD MILLION)    191
TABLE 255    CHINA: WESTERN BLOTTING MARKET, BY END USER,
2019–2026 (USD MILLION)    191
9.4.3    INDIA    192
9.4.3.1    Growing pharmaceutical & biotechnology industry in India, backed by government initiatives, to drive market growth    192
TABLE 256    INDIA: WESTERN BLOTTING MARKET, BY PRODUCT,
2019–2026 (USD MILLION)    193
TABLE 257    INDIA: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)    193
TABLE 258    INDIA: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019–2026 (USD MILLION)    193
TABLE 259    INDIA: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS, BY TYPE, 2019–2026 (USD MILLION)    193
TABLE 260    INDIA: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE,
 2019–2026 (USD MILLION)    194
TABLE 261    INDIA: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019–2026 (USD MILLION)    194
TABLE 262    INDIA: WESTERN BLOTTING MARKET, BY APPLICATION,
2019–2026 (USD MILLION)    194
TABLE 263    INDIA: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019–2026 (USD MILLION)    195
TABLE 264    INDIA: WESTERN BLOTTING MARKET, BY END USER,
2019–2026 (USD MILLION)    195
9.4.4    ROAPAC    195
TABLE 265    ROAPAC: WESTERN BLOTTING MARKET, BY PRODUCT,
2019–2026 (USD MILLION)    196
TABLE 266    ROAPAC: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)    196
TABLE 267    ROAPAC: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019–2026 (USD MILLION)    196
TABLE 268    ROAPAC: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS,
BY TYPE, 2019–2026 (USD MILLION)    196
TABLE 269    ROAPAC: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION)    197
TABLE 270    ROAPAC: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019–2026 (USD MILLION)    197
TABLE 271    ROAPAC: WESTERN BLOTTING MARKET, BY APPLICATION,
2019–2026 (USD MILLION)    197
TABLE 272    ROAPAC: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019–2026 (USD MILLION)    198
TABLE 273    ROAPAC: WESTERN BLOTTING MARKET, BY END USER,
2019–2026 (USD MILLION)    198
9.5    LATIN AMERICA    198
9.5.1    INCREASING ADOPTION OF PROTEOMICS TECHNOLOGIES IN THE REGION TO DRIVE MARKET GROWTH    198
TABLE 274    LATAM: WESTERN BLOTTING MARKET, BY PRODUCT,
2019–2026 (USD MILLION)    199
TABLE 275    LATAM: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)    199
TABLE 276    LATAM: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019–2026 (USD MILLION)    199
TABLE 277    LATAM: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS, BY TYPE, 2019–2026 (USD MILLION)    200
TABLE 278    LATAM: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION)    200
TABLE 279    LATAM: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019–2026 (USD MILLION)    200
TABLE 280    LATAM: WESTERN BLOTTING MARKET, BY APPLICATION,
2019–2026 (USD MILLION)    201
TABLE 281    LATAM: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019–2026 (USD MILLION)    201
TABLE 282    LATAM: WESTERN BLOTTING MARKET, BY END USER,
2019–2026 (USD MILLION)    201
9.6    MIDDLE EAST & AFRICA    202
9.6.1    PRESENCE OF A LARGER PATIENT POPULATION TO DRIVE THE MARKET IN THIS REGION    202
TABLE 283    MEA: WESTERN BLOTTING MARKET, BY PRODUCT,
2019–2026 (USD MILLION)    202
TABLE 284    MEA: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)    202
TABLE 285    MEA: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019–2026 (USD MILLION)    203
TABLE 286    MEA: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS, BY TYPE, 2019–2026 (USD MILLION)    203
TABLE 287    MEA: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION)    203
TABLE 288    MEA: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019–2026 (USD MILLION)    204
TABLE 289    MEA: WESTERN BLOTTING MARKET, BY APPLICATION,
2019–2026 (USD MILLION)    204
TABLE 290    MEA: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019–2026 (USD MILLION)    204
TABLE 291    MEA: WESTERN BLOTTING MARKET, BY END USER,
2019–2026 (USD MILLION)    205
10    COMPETITIVE LANDSCAPE    206
10.1    KEY PLAYER STRATEGIES    206
10.2    OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN THE WESTERN BLOTTING MARKET    207
10.3    MARKET SHARE ANALYSIS    208
FIGURE 27    WESTERN BLOTTING MARKET: MARKET SHARE ANALYSIS OF KEY PLAYERS, 2020    208
TABLE 292    WESTERN BLOTTING MARKET: DEGREE OF COMPETITION    208
10.4    REVENUE ANALYSIS    210
FIGURE 28    REVENUE ANALYSIS FOR KEY COMPANIES (2017–2020)    210
10.5    COMPANY EVALUATION QUADRANT    211
FIGURE 29    WESTERN BLOTTING MARKET (GLOBAL) COMPANY EVALUATION MATRIX, 2020    211
10.5.1    STARS    212
10.5.2    PERVASIVE PLAYERS    212
10.5.3    EMERGING LEADERS    212
10.5.4    PARTICIPANTS    212
10.6    COMPETITIVE LEADERSHIP MAPPING (START-UPS) (2020)    213
10.6.1    PROGRESSIVE COMPANIES    213
10.6.2    STARTING BLOCKS    213
10.6.3    DYNAMIC COMPANIES    213
10.6.4    RESPONSIVE COMPANIES    213
FIGURE 30    COMPETITIVE LEADERSHIP MAPPING: WESTERN BLOTTING MARKET    214
10.7    COMPETITIVE BENCHMARKING    215
TABLE 293    COMPANY PRODUCT FOOTPRINT (25 COMPANIES)    215
TABLE 294    COMPANY REGIONAL FOOTPRINT (25 COMPANIES)    216
10.8    COMPETITIVE SCENARIO    217
10.8.1    PRODUCT LAUNCHES    217
TABLE 295    WESTERN BLOTTING MARKET: PRODUCT LAUNCHES,
JANUARY 2018–OCTOBER 2021    217
10.8.2    DEALS    218
TABLE 296    WESTERN BLOTTING MARKET: DEALS, JANUARY 2018–OCTOBER 2021    218
10.8.3    OTHER DEVELOPMENTS    219
TABLE 297    WESTERN BLOTTING MARKET: OTHER DEVELOPMENTS,
JANUARY 2018–OCTOBER 2021    219

11    COMPANY PROFILES    220
11.1    KEY COMPANIES    220
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
11.1.1    BIO-RAD LABORATORIES, INC.    220
TABLE 298    BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW    220
FIGURE 31    COMPANY SNAPSHOT: BIO-RAD LABORATORIES, INC. (2020)    221
11.1.2    THERMO FISHER SCIENTIFIC INC.    224
TABLE 299    THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW    224
FIGURE 32    COMPANY SNAPSHOT: THERMO FISHER SCIENTIFIC INC. (2020)    225
11.1.3    DANAHER CORPORATION    228
TABLE 300    DANAHER CORPORATION: BUSINESS OVERVIEW    228
FIGURE 33    COMPANY SNAPSHOT: DANAHER CORPORATION (2020)    229
11.1.4    BIO-TECHNE CORPORATION    232
TABLE 301    BIO-TECHNE CORPORATION: BUSINESS OVERVIEW    232
FIGURE 34    BIO-TECHNE CORPORATION: COMPANY SNAPSHOT (2021)    233
11.1.5    MERCK KGAA    236
TABLE 302    MERCK KGAA: BUSINESS OVERVIEW    236
FIGURE 35    COMPANY SNAPSHOT: MERCK KGAA (2020)    237
11.1.6    PERKINELMER, INC.    239
TABLE 303    PERKINELMER, INC.: BUSINESS OVERVIEW    239
FIGURE 36    PERKINELMER, INC.: COMPANY SNAPSHOT (2020)    240
11.1.7    ABCAM PLC    242
TABLE 304    ABCAM PLC: BUSINESS OVERVIEW    242
FIGURE 37    COMPANY SNAPSHOT: ABCAM PLC (2020)    243
11.1.8    ENZO BIOCHEM, INC.    246
TABLE 305    ENZO BIOCHEM, INC.: BUSINESS OVERVIEW    246
FIGURE 38    COMPANY SNAPSHOT: ENZO BIOCHEM, INC. (2020)    247
11.1.9    LI-COR, INC.    249
TABLE 306    LI-COR, INC.: BUSINESS OVERVIEW    249
11.1.10    ADVANSTA INC.    251
TABLE 307    ADVANSTA INC.: BUSINESS OVERVIEW    251
11.1.11    CELL SIGNALING TECHNOLOGY, INC.    253
TABLE 308    CELL SIGNALING TECHNOLOGY, INC.: BUSINESS OVERVIEW    253
11.1.12    AZURE BIOSYSTEMS, INC.    254
TABLE 309    AZURE BIOSYSTEMS, INC.: BUSINESS OVERVIEW    254
11.1.13    BOSTER BIOLOGICAL TECHNOLOGY    256
TABLE 310    BOSTER BIOLOGICAL TECHNOLOGY: BUSINESS OVERVIEW    256
11.1.14    GENO TECHNOLOGY INC.    258
TABLE 311    GENO TECHNOLOGY INC.: BUSINESS OVERVIEW    258
11.1.15    STRESSMARQ BIOSCIENCES INC.    260
TABLE 312    STRESSMARQ BIOSCIENCES INC.: BUSINESS OVERVIEW    260
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
11.2    OTHER COMPANIES    261
11.2.1    F. HOFFMANN-LA ROCHE LTD.    261
11.2.2    ROCKLAND IMMUNOCHEMICALS, INC.    262
11.2.3    PRECISION BIOSYSTEMS    263
11.2.4    CLEAVER SCIENTIFIC LTD.    263
11.2.5    PROTEINTECH GROUP    264
11.2.6    ABNOVA CORPORATION    264
11.2.7    SINO BIOLOGICAL INC.    265
11.2.8    ABBEXA LTD.    265
11.2.9    COVALAB S.A.S.    266
11.2.10    BIORBYT LTD.    266
12    APPENDIX    267
12.1    DISCUSSION GUIDE    267
12.2    KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL    272
12.3    AVAILABLE CUSTOMIZATIONS    274
12.4    RELATED REPORTS    274
12.5    AUTHOR DETAILS    275"